InMed Pharmaceuticals Inc.: Form 8-K, filed Mar 30, 2026
Filed with the SEC on Mar 30, 2026 and accepted by EDGAR at Mar 30, 2026, 17:37 ET.
Items reported
- Item 3.01 Delisting notice
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001062993-26-001697. Last ingested by Listed: Nov 3, 2026, 21:04 ET. Listed shows no prices and gives no investment advice.